|
|
Volumn 16, Issue 5, 2013, Pages
|
|
Levosimendan use decreases atrial fibrillation in patients after coronary artery bypass grafting: a pilot study.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
HYDRAZONE DERIVATIVE;
PYRIDAZINE DERIVATIVE;
SIMENDAN;
ARTICLE;
COMORBIDITY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
DOUBLE BLIND PROCEDURE;
FEMALE;
HEART ATRIUM FIBRILLATION;
HUMAN;
INCIDENCE;
MALE;
METHODOLOGY;
MIDDLE AGED;
PILOT STUDY;
PLACEBO EFFECT;
POSTOPERATIVE COMPLICATION;
PREMEDICATION;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
STATISTICS;
TREATMENT OUTCOME;
TURKEY (REPUBLIC);
ANTI-ARRHYTHMIA AGENTS;
ATRIAL FIBRILLATION;
COMORBIDITY;
CORONARY ARTERY BYPASS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
HYDRAZONES;
INCIDENCE;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
PLACEBO EFFECT;
POSTOPERATIVE COMPLICATIONS;
PREMEDICATION;
PYRIDAZINES;
RISK ASSESSMENT;
TREATMENT OUTCOME;
TURKEY;
MLCS;
MLOWN;
|
|
EID: 84900358610
PISSN: None
EISSN: 15226662
Source Type: Journal
DOI: 10.1532/hsf98.2013190 Document Type: Article |
|
Times cited : (21)
|
|
References (0)
|
